The French drugmaker Sanofi has turned to Morgan Stanley for advice on a $9 billion-plus takeover bid, months after hiring a managing director from the US bank to lead its in-house M&A team.
Sanofi has made an unsolicited $9.3 billion approach for San Francisco-based Medivation, which it said has not expressed an interest in doing a deal.
